Get the Stockscreener App
192.30
1.62%
3.07
After Hours:
192.30
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Quest Diagnostics Inc stock is traded at $192.30, with a volume of 1.64M.
It is up +1.62% in the last 24 hours and up +10.84% over the past month.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
See More
Previous Close:
$189.23
Open:
$190
24h Volume:
1.64M
Relative Volume:
1.59
Market Cap:
$21.39B
Revenue:
$10.52B
Net Income/Loss:
$999.00M
P/E Ratio:
22.99
EPS:
8.3628
Net Cash Flow:
$1.22B
1W Performance:
+5.46%
1M Performance:
+10.84%
6M Performance:
+10.98%
1Y Performance:
+16.64%
1-Day Range:
$188.65
$193.46
1-Week Range:
$182.36
$193.46
52-Week Range:
$157.20
$197.55
Quest Diagnostics Inc Stock (DGX) Company Profile
Name
Quest Diagnostics Inc
Sector
Industry
Phone
(973) 520-2700
Address
500 PLAZA DRIVE, SECAUCUS
Compare DGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
192.30 | 21.05B | 10.52B | 999.00M | 1.22B | 8.3628 |
|
TMO
Thermo Fisher Scientific Inc
|
542.36 | 212.36B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
215.75 | 155.19B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
643.59 | 51.34B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
129.64 | 37.70B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
180.96 | 34.49B | 15.90B | 1.28B | 2.21B | 7.2842 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-25-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-17-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-23-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-28-24 | Resumed | Evercore ISI | In-line |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-29-23 | Initiated | Piper Sandler | Neutral |
| May-02-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-03-23 | Upgrade | Citigroup | Sell → Neutral |
| Jan-23-23 | Initiated | Evercore ISI | In-line |
| Nov-17-22 | Downgrade | Citigroup | Neutral → Sell |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Feb-23-22 | Downgrade | UBS | Buy → Neutral |
| Feb-02-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| May-04-21 | Upgrade | UBS | Neutral → Buy |
| Mar-12-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-21-20 | Upgrade | Argus | Hold → Buy |
| Jul-29-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-09-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jun-02-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-28-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Mar-27-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-19-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jul-15-19 | Downgrade | Goldman | Neutral → Sell |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-19 | Resumed | Credit Suisse | Neutral |
| Jan-31-19 | Downgrade | Argus | Buy → Hold |
| Jan-17-19 | Initiated | UBS | Neutral |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-30-18 | Downgrade | Goldman | Buy → Neutral |
View All
Quest Diagnostics Inc Stock (DGX) Latest News
Is Quest Diagnostics (DGX) Still Attractive After Recent Share Price Strength? - Yahoo Finance
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - GlobeNewswire Inc.
Quest Diagnostics Incorporated $DGX Shares Purchased by Peterson Wealth Services - MarketBeat
Principal Financial Group Inc. Sells 27,101 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Incorporated (DGX) Stock Analysis: Navigating Growth with a 6.57% Upside Potential - DirectorsTalk Interviews
New myeloma blood test offers alternative to painful bone marrow biopsies - stocktitan.net
Barclays Upgrades Quest Diagnostics to Overweight From Equalweight, Adjusts PT to $210 From $195 - marketscreener.com
AlphaQuest LLC Acquires 6,284 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Truist Financial Corp Decreases Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Strs Ohio Has $508,000 Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Esoteric Testing Research Report 2026 - GlobeNewswire Inc.
Alpha Cubed Investments LLC Grows Stock Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest 401(k) Win Suit Faces Scrutiny at Third Circuit - USA Herald
3rd Circ. Appears Skeptical Of Quest's Early Win In 401(k) Suit - Law360
Is Quest Diagnostics Incorporated in a bullish channelSell Signal & Reliable Intraday Trade Alerts - Mfd.ru
J. Safra Sarasin Holding AG Increases Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Cambiar Investors LLC Lowers Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics: A Continuing Bullish Case For A Leader Among Diagnostic Testing Brands - Seeking Alpha
A Look At Quest Diagnostics (DGX) Valuation After Recent Share Price Weakness - Yahoo Finance
Quest Diagnostics (NYSE:DGX) Cut to Hold at Wall Street Zen - MarketBeat
3rd Circ. Preview: Citizens Bank, Quest Fight Appeals In Jan. - Law360
Stock Market Recap: Can DCWS weather a recessionPortfolio Value Report & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Rakuten Investment Management Inc. Takes $4.71 Million Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Boston Common Asset Management LLC Has $17.92 Million Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Named to Fortune's Most Admired Companies List for 12th Year - Intellectia AI
Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year - Chartmill
Company testing 1 in 3 U.S. adults lands Fortune 'Most Admired' spot again - stocktitan.net
QRG Capital Management Inc. Sells 67,700 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Campbell & CO Investment Adviser LLC Takes $1.01 Million Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Market Moves: Does Apogee Enterprises Inc have consistent dividend growthWeekly Market Report & Community Driven Trade Alerts - baoquankhu1.vn
Short Interest in Quest Diagnostics Incorporated (NYSE:DGX) Increases By 38.4% - MarketBeat
Klein Pavlis & Peasley Financial Inc. Purchases Shares of 5,757 Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics (NYSE:DGX) Raised to Buy at Wall Street Zen - MarketBeat
How Do Investors Really Feel About Quest Diagnostics Inc? - Benzinga
TKG Advisors LLC Raises Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Nordea Investment Management AB Trims Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Aug PreEarnings: Is Quest Diagnostics Incorporated stock a value trapWatch List & AI Optimized Trade Strategies - baoquankhu1.vn
Quest Diagnostics Inc. (NYSE:DGX): A Prime Pick for Steady, Growing Dividends - Chartmill
Manning & Napier Advisors LLC Sells 11,341 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
100 million tests a year: Arizona lab names new CEO Jennifer Erickson - stocktitan.net
Market Rankings: What are Quest Diagnostics Incorporateds earnings expectationsJuly 2025 Market Mood & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Baird Adjusts Quest Diagnostics Price Target to $203 From $198, Maintains Neutral Rating - marketscreener.com
Quest Diagnostics Incorporated $DGX Shares Purchased by Nisa Investment Advisors LLC - MarketBeat
Best Testosterone Replacement Therapy (TRT) 2026: Taurus Meds Consumer Analysis Examines Online TRT Access and At-Home Testosterone Treatment Options - GlobeNewswire Inc.
SG Americas Securities LLC Sells 19,597 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year? - Eastern Progress
Quest Diagnostics About To Put More Money In Your Pocket (DGX) - Nasdaq
How cyclical is Quest Diagnostics Incorporated (QDI) stock compared to rivalsGDP Growth & Free Safe Capital Growth Stock Tips - Улправда
Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs - BioSpace
Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026 - Finviz
Can Quest Diagnostics Incorporated stock sustain institutional interestJuly 2025 PostEarnings & Verified Swing Trading Watchlists - Улправда
Quest Diagnostics Inc Stock (DGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.94%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):